Remibrutinib demonstrates favorable safety profile and sustained efficacy in chronic spontaneous urticaria over 52 weeks
| Autor: | Jain, Vipul, Giménez-Arnau, Ana, Hayama, Koremasa, Reich, Adam, Carr, Warner, Tillinghast, Jeffrey, Dahale, Swapnil, Lheritier, Karine, Walsh, Pauline, Zharkov, Artem, Hugot, Sophie, Haemmerle, Sibylle |
|---|---|
| Zdroj: | In The Journal of Allergy and Clinical Immunology February 2024 153(2):479-486 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|
Full Text from ScienceDirect